Variant report

Variant	esv3350913
Chromosome Location	chr21:47395974-47399172
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr21:47397006-47397624	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr21:47397406-47397463	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr21:47397460-47397610	HA-sp	spinal cord:	n/a	n/a
4	CTCF	chr21:47397380-47397530	AG04449	skin:	n/a	n/a
5	EP300	chr21:47397228-47397714	ECC-1	luminal epithelium:	n/a	n/a
6	FOS	chr21:47399108-47399111	MCF10A-Er-Src	breast:	n/a	n/a
7	FOS	chr21:47399109-47399126	MCF10A-Er-Src	breast:	n/a	n/a
8	FOSL2	chr21:47398969-47399292	HepG2	liver:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
9	JUND	chr21:47399054-47399186	HepG2	liver:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399102-47399113 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
10	JUND	chr21:47399073-47399203	K562	blood:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399102-47399113 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
11	MAZ	chr21:47398161-47398490	K562	blood:	n/a	chr21:47398447-47398456
12	MAZ	chr21:47397323-47398871	IMR90	lung:	n/a	chr21:47398447-47398456
13	POLR2A	chr21:47397016-47397095	H1-hESC	embryonic stem cell:	n/a	n/a
14	RAD21	chr21:47397469-47397580	H1-hESC	embryonic stem cell:	n/a	n/a
15	REST	chr21:47397438-47397662	SK-N-SH	brain:	n/a	n/a
16	SIN3A	chr21:47396968-47397640	H1-hESC	embryonic stem cell:	n/a	chr21:47397312-47397320
17	TBP	chr21:47397397-47397555	H1-hESC	embryonic stem cell:	n/a	n/a
18	TCF12	chr21:47395946-47396360	ECC-1	luminal epithelium:	n/a	n/a
19	USF2	chr21:47397456-47397475	H1-hESC	embryonic stem cell:	n/a	n/a
20	ZBTB7A	chr21:47399102-47399257	K562	blood:	n/a	n/a
21	ZNF143	chr21:47396982-47397994	H1-hESC	embryonic stem cell:	n/a	n/a
22	ZNF263	chr21:47396960-47397179	HEK293-T-REx	kidney:	n/a	n/a
23	ZNF263	chr21:47398040-47398688	HEK293-T-REx	kidney:	n/a	chr21:47398303-47398324 chr21:47398261-47398282

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:47398596-47398646	BJ	skin:	n/a
2	chr21:47396773-47396823	HUVEC	blood vessel:	n/a
3	chr21:47398596-47398646	HepG2	liver:	n/a
4	chr21:47398596-47398646	AG09319	gingival:	n/a
5	chr21:47396773-47396823	SK-N-SH_RA	brain:	n/a
6	chr21:47396773-47396823	Hepatocyte	liver:	n/a
7	chr21:47396773-47396823	HMEC	breast:	n/a
8	chr21:47398596-47398646	AoSMC	blood vessel:	n/a
9	chr21:47396773-47396823	AG04450	lung:	fetal
10	chr21:47396773-47396823	HCPEpiC	choroid plexus:	n/a
11	chr21:47396773-47396823	ECC-1	luminal epithelium:	n/a
12	chr21:47396773-47396823	AG09319	gingival:	n/a
13	chr21:47398596-47398646	CMK	blood:	n/a
14	chr21:47398596-47398646	HCF	heart:	n/a
15	chr21:47396773-47396823	SK-N-MC	brain:	n/a
16	chr21:47396773-47396823	ProgFib	skin:	n/a
17	chr21:47398596-47398646	HCPEpiC	choroid plexus:	n/a
18	chr21:47398596-47398646	HAEpiC	amniotic membrane:	n/a
19	chr21:47398596-47398646	A549	lung:	n/a
20	chr21:47398596-47398646	T-47D	breast:	n/a
21	chr21:47398596-47398646	SK-N-SH_RA	brain:	n/a
22	chr21:47398596-47398646	AG04450	lung:	fetal
23	chr21:47396773-47396823	HCF	heart:	n/a
24	chr21:47398596-47398646	IMR90	lung:	fetal
25	chr21:47398596-47398646	HRCEpiC	kidney:	n/a
26	chr21:47398596-47398646	RPTEC	kidney:	n/a
27	chr21:47396773-47396823	NHDF-neo	bronchial:	n/a
28	chr21:47396773-47396823	Caco-2	colon:	n/a
29	chr21:47398596-47398646	AG10803	skin:	n/a
30	chr21:47398596-47398646	AG04449	skin:	fetal
31	chr21:47398596-47398646	NT2-D1	testis:	n/a
32	chr21:47398596-47398646	AG09309	skin:	n/a
33	chr21:47398596-47398646	HUVEC	blood vessel:	n/a
34	chr21:47398596-47398646	NHBE	bronchial:	n/a
35	chr21:47398596-47398646	K562	blood:	n/a
36	chr21:47398596-47398646	HCM	heart:	n/a
37	chr21:47396773-47396823	HCM	heart:	n/a
38	chr21:47396773-47396823	AG10803	skin:	n/a
39	chr21:47396773-47396823	HAEpiC	amniotic membrane:	n/a
40	chr21:47398596-47398646	HCT-116	colon:	n/a
41	chr21:47396773-47396823	U87	brain:	n/a
42	chr21:47398596-47398646	U87	brain:	n/a
43	chr21:47398596-47398646	ECC-1	luminal epithelium:	n/a
44	chr21:47396773-47396823	Jurkat	blood:	n/a
45	chr21:47398596-47398646	SK-N-SH	brain:	n/a
46	chr21:47396773-47396823	HCT-116	colon:	n/a
47	chr21:47398596-47398646	Jurkat	blood:	n/a
48	chr21:47398596-47398646	HRE	kidney:	n/a
49	chr21:47396773-47396823	ovcar-3	ovarian:	n/a
50	chr21:47396773-47396823	HRE	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr21:47369464..47371619-chr21:47394987..47396620,2	MCF-7	breast:
2	chr21:47388213..47390098-chr21:47396842..47399384,2	MCF-7	breast:
3	chr21:47384997..47386531-chr21:47397126..47399086,2	MCF-7	breast:
4	chr21:47393834..47396182-chr21:47704275..47707193,2	MCF-7	breast:
5	chr21:47389572..47393249-chr21:47393676..47397258,4	K562	blood:
6	chr21:47393205..47395473-chr21:47397498..47399697,5	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-COL6A1-4	chr21:47398531-47398625	NONHSAT083005
2	lnc-COL6A1-4	chr21:47397218-47397295	NONHSAT083005
3	lnc-FTCD-2	chr21:47397451-47397653	XLOC_014129
4	lnc-FTCD-2	chr21:47395659-47396732	XLOC_014129
5	lnc-COL6A1-4	chr21:47399121-47399441	NONHSAT083005

Variant related genes	Relation type
COL6A1	TF binding region
COL6A1	CpG island
ENSG00000160294	chromatin interactions
ENSG00000182362	chromatin interactions
AFF4	miRNA target sites

Extended variants
information (count: 126 )
Associated
traits (count: 36 )

Variant overlapped rSNPs/rCNVs (count:126 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs545627383	chr21:47396002-47396003	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs143795882	chr21:47396022-47396023	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs540114152	chr21:47396027-47396028	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs552072703	chr21:47396028-47396029	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
5	rs570376531	chr21:47396030-47396031	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
6	rs537608415	chr21:47396037-47396038	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
7	rs555684501	chr21:47396049-47396050	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
8	rs573676398	chr21:47396059-47396060	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
9	rs534458562	chr21:47396064-47396065	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
10	rs4369960	chr21:47396073-47396074	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs56364138	chr21:47396085-47396086	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs115526573	chr21:47396099-47396100	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
13	rs150645677	chr21:47396100-47396101	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
14	rs542807477	chr21:47396101-47396102	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
15	rs560968636	chr21:47396177-47396178	Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
16	rs529374621	chr21:47396209-47396210	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
17	rs541197828	chr21:47396210-47396211	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
18	rs4369961	chr21:47396308-47396309	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
19	rs181836977	chr21:47396465-47396466	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
20	rs183772775	chr21:47396483-47396484	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
21	rs551806329	chr21:47396562-47396563	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
22	rs187975477	chr21:47396573-47396574	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
23	rs568887158	chr21:47396584-47396585	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
24	rs181239051	chr21:47396586-47396587	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
25	rs549544146	chr21:47396589-47396590	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
26	rs2005950	chr21:47396594-47396595	Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs535244304	chr21:47396622-47396623	Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
28	rs78636504	chr21:47396730-47396731	Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
29	rs571018966	chr21:47396843-47396844	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs538201767	chr21:47396845-47396846	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs561892333	chr21:47396876-47396877	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs575489023	chr21:47396899-47396900	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs145677591	chr21:47396918-47396919	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs527686203	chr21:47396977-47396978	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs186222361	chr21:47396989-47396990	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs116587309	chr21:47397026-47397027	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs533969336	chr21:47397041-47397042	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs149793500	chr21:47397070-47397071	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs191973430	chr21:47397161-47397162	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs199965445	chr21:47397169-47397170	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs540436187	chr21:47397181-47397182	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs60864463	chr21:47397208-47397209	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs57301453	chr21:47397215-47397216	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs57075267	chr21:47397217-47397218	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs56905329	chr21:47397223-47397224	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs12483362	chr21:47397225-47397226	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs374980427	chr21:47397238-47397239	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs537713352	chr21:47397252-47397253	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs545416800	chr21:47397312-47397313	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs181845167	chr21:47397319-47397320	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:36)

Disease	PMID	Source
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Breast cancer	17899364	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:231 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:47392400-47396800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
2	chr21:47392400-47397600	Active TSS	iPS-15b Cell Line	embryonic stem cell
3	chr21:47392800-47397600	Active TSS	HUES48 Cell Line	embryonic stem cell
4	chr21:47394400-47396000	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
5	chr21:47394400-47396000	Bivalent Enhancer	Fetal Lung	lung
6	chr21:47394400-47400400	Weak transcription	Pancreatic Islets	Pancreatic Islet
7	chr21:47394600-47396000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
8	chr21:47394800-47400800	Weak transcription	Pancreas	Pancrea
9	chr21:47395000-47396000	Enhancers	Primary T killer memory cells from peripheral blood	blood
10	chr21:47395000-47397400	Active TSS	HUES6 Cell Line	embryonic stem cell
11	chr21:47395000-47398400	Weak transcription	Brain Substantia Nigra	brain
12	chr21:47395000-47400600	Weak transcription	Dnd41	blood
13	chr21:47395000-47401000	Enhancers	Fetal Muscle Leg	muscle
14	chr21:47395200-47396000	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr21:47395200-47396200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
16	chr21:47395200-47400600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr21:47395200-47400800	Weak transcription	Left Ventricle	heart
18	chr21:47395200-47401000	Weak transcription	Gastric	stomach
19	chr21:47395200-47401000	Weak transcription	HSMMtube	muscle
20	chr21:47395400-47396000	Enhancers	Rectal Smooth Muscle	rectum
21	chr21:47395400-47396200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr21:47395400-47396400	Weak transcription	Right Ventricle	heart
23	chr21:47395400-47396600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr21:47395400-47396600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
25	chr21:47395400-47396600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
26	chr21:47395400-47396600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr21:47395400-47396800	Active TSS	ES-I3 Cell Line	embryonic stem cell
28	chr21:47395400-47397000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr21:47395400-47397000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr21:47395400-47397200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr21:47395400-47397200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr21:47395400-47397200	Weak transcription	Ovary	ovary
33	chr21:47395400-47397400	Weak transcription	NHDF-Ad	bronchial
34	chr21:47395400-47398000	Weak transcription	Fetal Heart	heart
35	chr21:47395400-47398200	Weak transcription	Muscle Satellite Cultured Cells	--
36	chr21:47395400-47398200	Weak transcription	Osteobl	bone
37	chr21:47395400-47398400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr21:47395400-47398600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr21:47395400-47400600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
40	chr21:47395400-47400600	Weak transcription	Adipose Nuclei	Adipose
41	chr21:47395400-47400800	Weak transcription	Right Atrium	heart
42	chr21:47395400-47400800	Weak transcription	HSMM	muscle
43	chr21:47395400-47401000	Weak transcription	HMEC	breast
44	chr21:47395600-47396000	Weak transcription	Colon Smooth Muscle	Colon
45	chr21:47395600-47396000	Enhancers	Stomach Smooth Muscle	stomach
46	chr21:47395600-47396200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr21:47395600-47396600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr21:47395600-47396600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr21:47395600-47396600	Weak transcription	H9 Cell Line	embryonic stem cell
50	chr21:47395600-47396600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links